Brief: T Investment Limited Reports 9.89% Stake In I-Mab As Of November 22- SEC Filing
Dec 1 (Reuters) - T INVESTMENT LIMITED:
* T INVESTMENT LIMITED REPORTS 9.89% STAKE IN I-MAB AS OF
NOVEMBER
22- SEC FILING
* T INVESTMENT LIMITED SAYS PURCHASED I-MAB'S SHARES BASED
ON
BELIEF THAT SHARES REPRESENTED ATTRACTIVE INVESTMENT OPPORTUNITY
Further company coverage: IMAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NovaBridge Biosciences
See all newsBrief: Visara Secures Exclusive Option For Potential Acquisition Of Yol104-2 For Ocular Surface Squamous Neoplasia
Brief: Visara Expands Ophthalmology Pipeline With Exclusive License For Investigational Nerve Growth Factor Therapy For Neurotrophic Keratitis
Brief: Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China
Brief: Novabridge Biosciences Announces Expanded Givastomig Safety And Efficacy Data
NovaBridge Biosciences expected to post a loss of 13 cents a share - Earnings Preview